Astragenol
CAS No. 86541-79-9
Astragenol( —— )
Catalog No. M29416 CAS No. 86541-79-9
Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 33 | In Stock |
|
| 25MG | 67 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 169 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAstragenol
-
NoteResearch use only, not for human use.
-
Brief DescriptionAstragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.
-
DescriptionAstragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86541-79-9
-
Formula Weight980.42
-
Molecular FormulaC60H99O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 50 mg/mL (101.89 mM)
-
SMILESCC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@](C)(O5)CC[C@H]5C(C)(O)C)[C@@H](O)C[C@](C)4[C@]3([H])C[C@H](O)[C@@]12[H]CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@](C)(O5)CC[C@H]5C(C)(O)C)[C@@H](O)C[C@](C)4[C@]3([H])C[C@H](O)[C@@]12[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
GIP (1-30) amide (Hu...
GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions.
-
RGD-4C
RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. The Arg-Gly-Asp (RGD) sequence serves as the primary integrin recognition site in extracellular matrix proteins, and peptides containing this sequence can mimic the recognition specificity of the matrix proteins. RGD-4C is a αv-integrin ligand, can conjugate with bioactive molecule to exert antitumor effects in animal models.
-
Biotin-MBP Derivatiz...
Biotin-MBP Derivatized Peptide
Cart
sales@molnova.com